Výsledky vyhledávání - "E. Skopelitis"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Atorvastatin therapy is associated with improvement of oxidized low-density lipoprotein cholesterol levels, which correlates with the degree of stenosis in patients with carotid atheromatosis with and without prior angioplasty

Autor: S, Kougialis, E, Skopelitis, T, Gialernios, S, Nikolaou, A, Kroustalis, E, Katsadorou, K, Gialernios, A, Zervou, E, Gika, A, Polydorou, V, Polydorou, C, Drakoulis, N, Iliopoulos, I, Dermitzakis, H, Mpilinis

Publikováno v: International angiology : a journal of the International Union of Angiology. 29(4)

Oxidized low-density lipoprotein (oxLDL) is a pivotal factor of the atheromatous process. Statins reduce atheromatosis and cardiovascular risk. The aim of the present study was to investigate the effect of statin therapy on circulating oxLDL and the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2acfecfecf02a65afd6b71a9cde19705
https://pubmed.ncbi.nlm.nih.gov/20671652

Zobrazit plný text záznamu

Impact of the metabolic syndrome and its components combinations on arterial stiffness in Type 2 diabetic men

Autor: D, Levisianou, A, Melidonis, E, Adamopoulou, E, Skopelitis, A, Koutsovasilis, I, Protopsaltis, M, Zairis, S, Kougialis, I, Skoularigis, G, Koukoulis, S, Foussas, F, Triposkiadis

Publikováno v: International angiology : a journal of the International Union of Angiology. 28(6)

Arterial stiffness (AS) is a risk marker of atherosclerosis and coronary artery disease, yet its association with metabolic syndrome (MS) in diabetic patients is not established. The aim of this study was to investigate possible association of MS or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c32b272e133eb2443e94306fa3352d4c
https://pubmed.ncbi.nlm.nih.gov/20087288

Zobrazit plný text záznamu

5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study

Autor: N, Tsavaris, C, Kosmas, M, Vadiaka, E, Skopelitis, P, Kopteridis, S, Pamouki, M, Efremidis, H, Kasparian, I, Moisakis, D, Sakelariou, C, Koufos

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 10(2)

Cardiotoxicity associated with 5-fluorouracil (5FU) administration is infrequently reported in the literature, albeit case reports of acute coronary syndromes have been published. In the present study, patients undergoing 5FU chemotherapy were tested

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::33db571f30735c097291a4beeb2b1682
https://pubmed.ncbi.nlm.nih.gov/17343330

Zobrazit plný text záznamu

Breast cancer following curative chemotherapy for non-Hodgkin's lymphoma and the effect of drug resistance proteins to the final outcome. A retrospective study

Autor: N, Tsavaris, C, Kosmas, N, Kavantzas, A, Lazaris, E, Skopelitis, A, Dimitrakopoulos, M P, Siakantaris, E, Papalambros, N, Diamantis, E, Patsouris, G A, Pangalis

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 10(1)

To investigate the overall survival (OS) of patients developing breast cancer (BC) after curative chemotherapy for non-Hodgkin's lymphoma (NHL) and to evaluate the possible effect on the patients' outcome of the expression of drug resistance-related

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b6f92b3c8ec23c6caa8233ab93b3516e
https://pubmed.ncbi.nlm.nih.gov/17335134

Zobrazit plný text záznamu

Etoposide, leucovorin (LV) and 5-fluorouracil (5-FU) in 5-FU+LV pre-treated patients with advanced colorectal cancer

Autor: G. Papastratis, E. Skopelitis, C. Kosmas, George C. Zografos, K. Gennatas, E. Margaris, Sofia Rokana, M. Vadiaka, Gregory Kouraklis, N. Tsavaris, V. Xila

Publikováno v: Journal of chemotherapy (Florence, Italy). 14(4)

In the present study, we evaluated the efficacy and safety of the weekly combination of etoposide, leucovorin (LV) and 5-fluorouracil (5-FU) when administered as second-line chemotherapy in patients with relapsed/refractory advanced colorectal cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f2f5fa02f8e6719144400b8ae2135b
https://pubmed.ncbi.nlm.nih.gov/12420860

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání